Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon M Miller

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Plos Pathogens|October 8, 2016
Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV InfectionBrodie Miles, Shannon M Miller, Joy M Folkvord, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2020
Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activityHélène G Bazin, Laura S Bess, Mark T Livesay, et al.
NPJ Vaccines|July 10, 2023
A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in miceShannon M Miller, Bethany Crouse, Linda Hicks, et al.
Frontiers in Immunology|March 16, 2019
Species-Specific Structural Requirements of Alpha-Branched Trehalose Diester Mincle AgonistsAlyson J Smith, Shannon M Miller, Cassandra Buhl, et al.
Nature Biotechnology|September 8, 2022
High-throughput continuous evolution of compact Cas9 variants targeting single-nucleotide-pyrimidine PAMsTony P Huang, Zachary J Heins, Shannon M Miller, et al.
Journal of Medicinal Chemistry|December 7, 2019
Aryl Trehalose Derivatives as Vaccine Adjuvants for <i>Mycobacterium tuberculosis</i>Kendal T Ryter, George Ettenger, Omer K Rasheed, et al.
Nature Biotechnology|June 12, 2019
Author Correction: Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editorsTony P Huang, Kevin T Zhao, Shannon M Miller, et al.
Frontiers in Immunology|March 27, 2020
Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in MiceShannon M Miller, Van Cybulski, Margaret Whitacre, et al.
Nature Biotechnology|May 22, 2019
Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editorsTony P Huang, Kevin T Zhao, Shannon M Miller, et al.
Frontiers in Immunology|November 11, 2021
Advancing Adjuvants for <i>Mycobacterium tuberculosis</i> TherapeuticsAna B Enriquez, Angelo Izzo, Shannon M Miller, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Plos Pathogens|October 8, 2016
Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV InfectionBrodie Miles, Shannon M Miller, Joy M Folkvord, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2020
Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activityHélène G Bazin, Laura S Bess, Mark T Livesay, et al.
NPJ Vaccines|July 10, 2023
A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in miceShannon M Miller, Bethany Crouse, Linda Hicks, et al.
Frontiers in Immunology|March 16, 2019
Species-Specific Structural Requirements of Alpha-Branched Trehalose Diester Mincle AgonistsAlyson J Smith, Shannon M Miller, Cassandra Buhl, et al.
Nature Biotechnology|September 8, 2022
High-throughput continuous evolution of compact Cas9 variants targeting single-nucleotide-pyrimidine PAMsTony P Huang, Zachary J Heins, Shannon M Miller, et al.
Journal of Medicinal Chemistry|December 7, 2019
Aryl Trehalose Derivatives as Vaccine Adjuvants for <i>Mycobacterium tuberculosis</i>Kendal T Ryter, George Ettenger, Omer K Rasheed, et al.
Nature Biotechnology|June 12, 2019
Author Correction: Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editorsTony P Huang, Kevin T Zhao, Shannon M Miller, et al.
Frontiers in Immunology|March 27, 2020
Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in MiceShannon M Miller, Van Cybulski, Margaret Whitacre, et al.
Nature Biotechnology|May 22, 2019
Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editorsTony P Huang, Kevin T Zhao, Shannon M Miller, et al.
Frontiers in Immunology|November 11, 2021
Advancing Adjuvants for <i>Mycobacterium tuberculosis</i> TherapeuticsAna B Enriquez, Angelo Izzo, Shannon M Miller, et al.
Pageof 4